Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pfizer Inc. stock logo
PFE
Pfizer
$24.74
+0.6%
$24.79
$20.92
$30.43
$140.77B0.5243.71 million shs37.00 million shs
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$106.02
+0.1%
$124.75
$72.93
$144.65
$4.52B1.821.40 million shs1.00 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pfizer Inc. stock logo
PFE
Pfizer
+0.57%-4.21%+3.81%+5.45%-13.97%
Shake Shack, Inc. stock logo
SHAK
Shake Shack
+0.10%+2.15%-24.80%-18.40%+1.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Pfizer Inc. stock logo
PFE
Pfizer
4.7771 of 5 stars
2.23.04.24.52.31.73.1
Shake Shack, Inc. stock logo
SHAK
Shake Shack
4.443 of 5 stars
4.11.00.01.62.82.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pfizer Inc. stock logo
PFE
Pfizer
2.39
Hold$28.1213.66% Upside
Shake Shack, Inc. stock logo
SHAK
Shake Shack
2.29
Hold$133.0525.49% Upside

Current Analyst Ratings Breakdown

Latest SHAK and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/6/2025
Pfizer Inc. stock logo
PFE
Pfizer
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$25.00 ➝ $26.00
8/6/2025
Pfizer Inc. stock logo
PFE
Pfizer
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$32.00 ➝ $33.00
8/6/2025
Pfizer Inc. stock logo
PFE
Pfizer
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$27.00 ➝ $28.00
8/1/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$122.00 ➝ $126.00
8/1/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$168.00 ➝ $160.00
8/1/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingStrong-Buy ➝ Strong-Buy$165.00 ➝ $160.00
7/31/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$105.00 ➝ $110.00
7/25/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$100.00 ➝ $140.00
7/18/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$134.00 ➝ $148.00
7/17/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$115.00 ➝ $125.00
7/17/2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$166.00 ➝ $168.00
(Data available from 8/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.21$4.36 per share5.67$15.66 per share1.58
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$1.25B3.61$3.43 per share30.92$12.16 per share8.72
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.8813.168.160.8816.84%21.42%9.12%11/4/2025 (Estimated)
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$10.21M$0.46230.4966.262.421.50%9.78%2.83%10/29/2025 (Estimated)

Latest SHAK and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.58$0.78+$0.20$0.51$13.43 billion$14.65 billion
7/31/2025Q2 2025
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$0.37$0.44+$0.07$0.41$352.56 million$356.47 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.95%N/A91.49%16 Years
Shake Shack, Inc. stock logo
SHAK
Shake Shack
N/AN/AN/AN/AN/A

Latest SHAK and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pfizer Inc. stock logo
PFE
Pfizer
0.65
1.16
0.85
Shake Shack, Inc. stock logo
SHAK
Shake Shack
0.48
1.92
1.89

Institutional Ownership

CompanyInstitutional Ownership
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Shake Shack, Inc. stock logo
SHAK
Shake Shack
86.07%

Insider Ownership

CompanyInsider Ownership
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Shake Shack, Inc. stock logo
SHAK
Shake Shack
8.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable
Shake Shack, Inc. stock logo
SHAK
Shake Shack
12,82642.69 million39.06 millionOptionable

Recent News About These Companies

Two Brits try Shake Shack Secret Menu!
Shake Shack’s Spark chili menu brings the heat without the burn
Shake Shack coming to Pembroke Pines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Pfizer stock logo

Pfizer NYSE:PFE

$24.74 +0.14 (+0.57%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$24.78 +0.04 (+0.15%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Shake Shack stock logo

Shake Shack NYSE:SHAK

$106.02 +0.10 (+0.10%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$105.06 -0.96 (-0.90%)
As of 08/29/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Shake Shack Inc. owns, operates, and licenses Shake Shack restaurants (Shacks) in the United States and internationally. Its Shacks offers hamburgers, chicken, hot dogs, crinkle cut fries, shakes, frozen custard, beer, wine, and other products. The company was founded in 2001 and is headquartered in New York, New York.